Singh emphasised that India’s pharmaceutical industry is not only significant in volume but also plays a crucial role in ...
But the YoY growth is expected to decline for the Indian Pharmaceutical Market (IPM), projected at approximately 8 per cent, ...
India's pharmaceutical and meditech exports have become the fourth-largest export sector, with 16 blockbuster drugs in the pipeline. Despite global slowdown concerns, the sector is experiencing double ...
The pharmaceutical industry is poised for an 8.5% revenue growth, spurred by domestic formulations and niche US market ...
Pharma Industry revenue growth is likely to grow by 8.5 per cent (YoY) and will be driven by domestic formulations and niche launches in the US market, according to a report by Axis Securities. The ...
Dr. Jitendra Singh emphasised that biotechnology will drive India's next industrial revolution, fueled by the rapid growth of ...
Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...
This issue underscores the broader challenge of maintaining stringent quality controls in the pharmaceutical supply chain, ...
India's pharmaceutical and meditech exports continue to grow despite global economic slowdown, with robust double-digit ...
India's pharmaceutical and meditech exports are expected to continue strong growth despite global economic slowdown, driven ...
Hyundai Motor Co expects India to be a fast-growing market and plans to make it a global manufacturing hub, a top company ...